IDT Australia LimitedASX: IDT

Investor and Medicinal Cannabis Update

· Issued by IDT Australia Limited

Filed with ASX · · 14 pages · English

GMP* Manufactured (Medicinal) Cannabis products are mandatory for entry into highly regulated markets; and are emerging as a key market opportunity to convert lower value biomass into higher value differentiated products Cannabis biomass (dry flower material) is becoming commoditised as crop volumes increase and exert downward pressure on prices The global cannabis industry is expanding into more

IDT Australia Limited on 6ix

Story so far

Earlier from IDT Australia

Later from IDT Australia

All IDT Australia news releases